Continual illness prevention and administration platform Lark Well being introduced will probably be accessible by way of CVS Caremark’s Level Options Administration program.
CVS Caremark prospects can have the flexibility to entry Lark’s teaching packages, together with the corporate’s GLP-1 price containment and weight problems administration choices, by way of CVS Caremark’s platform.
In a LinkedIn publish, Lark stated it can tailor a holistic program that’s scalable, accessible 24/7 and constructed upon particular employer wants, together with medical price financial savings, habits change-driven weight reduction options for applicable members and predictive modeling to extend insights into personalised GLP-1 administration and commencement.
Lark Well being provides packages to assist stop and handle hypertension and diabetes. The Lark app can be utilized with related gadgets, reminiscent of scales, blood stress displays and blood glucose displays. The app may also be used to speak with Lark coaches.
“Employers are responding to large demand for GLP-1 drugs and weight administration amongst staff and given the prices of those medication, they want versatile options that match their members’ wants,” Julia Hu, Lark Well being CEO and cofounder, stated on LinkedIn.
THE LARGER TREND
In 2024, Lark Well being appointed Darren Eckberg as chief progress officer to supervise the growth of the corporate’s AI-enabled GLP-1 cost-containment know-how.
Eckberg beforehand held government positions at EnvisionRx/Ceremony Help, Specific Scripts, Prime Therapeutics and IngenioRx/Anthem.
In 2022, Lark Well being developed an AI-enabled platform geared toward stopping and managing atherosclerotic heart problems and coronary artery illness in partnership with Roche Diagnostics.
In 2021, Lark Well being secured $100 million in a Collection D funding spherical. Deerfield Administration Firm led the elevate, with participation from PFM Well being Sciences and returning buyers Franklin Templeton, King River Capital, Castlepeak, IPD, Olive Tree Capital and Marvell Expertise cofounder Weili Dai.
